| SESSION 3: DIFFERENT CONTRACEPTIVE METHODS
(I.E. HORMONAL, IUDS, IMPLANTS) |
 |
| nr. |
title |
1st
author |
abstract |
| P055 |
Experience with Implanon in a North East London family planning clinic
|
S. Gupta (UK) |
abstract |
| P056 |
Progestogen only contraception and venous thromboembolism – is accepted clinical practice at odds
with manufacturer’s guidance?
|
J. Brotherston (UK) |
abstract |
| P057 |
How late can you give Depo-medroxyprogesterone acetate?
|
S. Jones (UK) |
abstract |
| P058 |
Long-term safety and efficacy of extremely low-dose combined oral contraception containing 15 mg of
ethinylestradiol and 60 mg of gestodene
|
D. Driák (Czech Republic) |
abstract |
| P059 |
An assessment of the infection risk associated with intrauterine device insertion in two different clinical
situations
|
C. Johnman (UK) |
abstract |
| P060 |
A study on knowledge of women about condom and its relationship with the usage of condom in their
partners
|
Z. Sooki (Iran) |
abstract |
| P061 |
Levonogestrel-releasing intrauterine devices: clinical experience and acceptability
|
M. Díaz-Vega (Spain) |
abstract |
| P062 |
A comparative study on the dislocation rate of the Mirena1 and the Multiload 3751 intrauterine device
|
G.S. Merki-Feld (Switzerland) |
abstract |
| P063 |
Transfallopian expulsion of IUCD – a case report
|
I. Samardziski (Macedonia) |
abstract |
| P064 |
Study of ovarian function in amenorrheic users of Mirena1
|
I.C. Barbosa (Brazil) |
abstract |
| P065 |
Medical eligibility criteria for using modern oral contraceptives in women with type 1 diabetes
|
S.V. Nikitine (Russia) |
abstract |
| P066 |
Acceptability, safety and premenstrual symptomatology in women using an oral contraceptive
containing gestodene 60mcg/ethinylestradiol 15mcg
|
I.C. Barbosa (Brazil) |
abstract |
| P067 |
Cycle control in women using an oral contraceptive containing gestodene 60mcg/ethinylestradiol
15mcg
|
I.C. Barbosa (Brazil) |
abstract |
| P068 |
A survey of Norplant and DMPA: effects on women’s weight and blood pressure
|
Shohreh.ziaei (Iran) |
abstract |
| P069 |
Patient satisfaction and preference with the EVRA transdermal contraceptive patch compared to the
previous contraceptive method
|
F. Weisberg (Canada) |
abstract |
| P070 |
NuvaRing improves cycle control in German women
|
S. Baumgaertner (Germany) |
abstract |
| P071 |
Acceptability and tolerability of NuvaRing in Ireland
|
S. Jones (UK) |
abstract |
| P072 |
The Mirena intrauterine system and user acceptability
|
J. Bowie (UK) |
abstract |
| P073 |
NuvaRing’s contraceptive efficacy and tolerability are comparable to an oral contraceptive
|
K. Oddsson (Iceland) |
abstract |
| P074 |
Satisfaction and compliance of 1333 users of transdermal contraception in private gynaecological
practice in Austria
|
C.J. Gruber (Austria) |
abstract |
| P075 |
Sociodemographic properties and contraception use of pregnants before pregnancy
|
F. Altıntasoglu (Turkey) |
abstract |
| P076 |
Continued use of Implanon inserted following termination of pregnancy
|
M. Preston (UK) |
abstract |
| P077 |
Effect of Implanon1 on lumbar bone mineral density
|
B. Dilbaz (Turkey) |
abstract |
| P078 |
Effect of Implanon® on serum lipids, liver function tests and hemoglobin levels |
B. Dilbaz (Turkey) |
abstract |
| P079 |
One year follow-up of patients on Implanon® for contraception: a multicentric prospective study
|
Y. Yakut (Turkey) |
abstract |
| P080 |
Vasectomy outcome of voluntary male surgical contraception at a metropolitan maternity hospital |
B. Dilbaz (Turkey) |
abstract |
| P081 |
Vesical calculus formation around a migrated Copper-T 280a
|
S. Dede (Turkey) |
abstract |
| P082 |
Implanon: our three year experience
|
D. Sobral (Portugal) |
abstract |
| P083 |
The effects of increasing the copper load on IUD performance: a systematic review
|
P. O’Brien (UK) |
abstract |
| P084 |
The TCu380 Slimline or TCu380A: a systematic review of comparative data
|
P. O’Brien(UK) |
abstract |
| P085 |
The comparison of analgesic effects of local anesthesia and piroxicam in legal abortions
|
E.Z. Tuzcular Vural (Turkey) |
abstract |
| P086 |
The comparative trial of the effects on various parameters of two 30 µg EE monophasic oral
contraceptives containing 0.3 mg norgestrel and 0.075 mg gestodene |
E.Z. Tuzcular Vural (Turkey) |
abstract |
| P087 |
The experience with depot-medroxyprogesterone acetate used as a contraceptive method among
Turkish women
|
Z. Vural (Turkey) |
abstract |
| P088 |
The frequency of complications in IUD users in family planning clinic, Shariati hospital, Tehran (1997–
2002)
|
A. Hamid (Iran) |
abstract |
| P089 |
The colonization of IUDs with Actinomyces and other bacteriae
|
I. Gönenç (Turkey) |
abstract |
| P090 |
The effect of depot-medroxyprogesterone acetate on bone mineral density and lipid metabolism |
I. Gönenç (Turkey) |
abstract |
| P091 |
Subdermal Implant: our experience in teenagers
|
A. Pereira (Portugal) |
abstract |
| P092 |
The effect of Implanon® and a non-medicated intrauterine device on the development of breastfed
infants
|
S. Taneepanichskul (Thailand) |
abstract |
| P093 |
Satisfaction and non-contraceptive benefits with NuvaRing1, a novel vaginal combined contraceptive
method in a clinical experience program in Brazil
|
N. de Melo (Brazil) |
abstract |
| P094 |
Ultrasonographic features of the endometrium and the ovaries in women on Implanon1
|
T. Van den Bosch (Belgium) |
abstract |
| P095 |
Bacterial vaginal flora in Implanon users
|
G.G.G. Donders (Belgium) |
abstract |
| P096 |
Mechanical contraceptive methods and their complications in Iran
|
F. Hejazi (Iran) |
abstract |
| P097 |
Comparision of efficacy and complications of ınsertion of IUD in postplacental/postpartum period and
postpuerperal/ınterval period: 1 year follow-up*
|
K. Eroglu (Turkey) |
abstract |
|
|
|
|